Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Rejected in U.S. High Court Bid to Reinstate Abbott Verdict
Bloomberg
Tuesday, February 21, 2012 - 10:36am
tags:
JNJ, Abbott Laboratories, Humira, patents
Enanta partners with Novartis to develop new drug to treat hepatitis C virus
Boston Globe, MA
Tuesday, February 21, 2012 - 9:36am
tags:
Novartis, Enanta, hepatitis C, EDP-239
Feds Subpoena Bristol-Myers Over Abilify Marketing
Pharmalot
Tuesday, February 21, 2012 - 9:35am
tags:
Abilify, Bristol-Myers Squibb
Corcept Scores A First With Cushing's Treatment Approval In The U.S.
Seeking Alpha
Tuesday, February 21, 2012 - 9:34am
tags:
Cushing's syndrome, Corcept Therapeutics, Korlym, Novartis, Signifor
Threshold Pharma's TH-302 for pancreatic cancer shows positive Phase 2b results
Yahoo/Fly on the Wall
Tuesday, February 21, 2012 - 9:02am
tags:
Threshold Pharmaceuticals, pancreatic cancer, TH-302
Friday's Overreaction Provides Great Entry Point For Gilead
Seeking Alpha
Tuesday, February 21, 2012 - 9:01am
tags:
Gilead, Vertex, hepatitis C, Pharmasset, PSI-7977
US FDA staff focus on safety of Forest lung drug
Reuters
Tuesday, February 21, 2012 - 9:00am
tags:
FDA, Forest Labs, COPD, aclidinium bromide, Almirall
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
TheStreet.com
Tuesday, February 21, 2012 - 8:59am
tags:
Elan, Alzheimer's disease, bapineuzumab, monoclonal antibodies
Pfizer eyes tie-ups with more Chinese drugmakers
Reuters
Tuesday, February 21, 2012 - 8:58am
tags:
Pfizer, China, Zhejiang Hisun
After Gilead's Drop: Hedging 5 Biotechnology Stocks
Seeking Alpha
Monday, February 20, 2012 - 1:44pm
tags:
Gilead, Acorda, Amylin, Celgene, United Therapeutics
Amyris Finds Scaling Up More Difficult Than Expected
Seeking Alpha
Monday, February 20, 2012 - 12:28pm
tags:
Amyris
What's Next For Amarin's Lucky Investors?
Seeking Alpha
Monday, February 20, 2012 - 12:27pm
tags:
Amarin, GSK
China Biotech In Review: GSK To Explore Synthetic Versions Of Chinese Medicines
Seeking Alpha
Monday, February 20, 2012 - 12:24pm
tags:
GSK, China, Tianyin Pharmaceutical, Beijing Leadman Biochemistry
Biotie Being Courted by Potential Partners for Alzheimer’s Drug
Bloomberg
Monday, February 20, 2012 - 12:22pm
tags:
BioTie Therapies, Alzheimer's disease, SYN120, Roche
Pfizer plans to float animal healthcare business-FT
Reuters
Monday, February 20, 2012 - 12:21pm
tags:
Pfizer, animal health
5 Overlooked Healthcare Stocks To Consider Now
Seeking Alpha
Sunday, February 19, 2012 - 11:24am
tags:
Exelixis, Momenta, Neurocrine Biosciences, Thoratec, Syneron Medical
Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals
Bradenton Herald, FL
Sunday, February 19, 2012 - 11:20am
tags:
Par Pharmaceutical, Edict Pharmaceuticals
Avedro Raises Additional Series C and Debt Funding
TechFinance
Sunday, February 19, 2012 - 11:19am
tags:
Avedro
How Does Big Pharma Boost Its Returns?
Motley Fool
Sunday, February 19, 2012 - 11:16am
tags:
Novartis, GSK, Merck
Taking Advantage Of Johnson & Johnson's Unstickiness
Seeking Alpha
Sunday, February 19, 2012 - 11:10am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.